“Some will make millions in marijuana stocks, but many more will lose their shirts,” states the author of today’s article, which focuses on the recent run-up in marijuana stocks and how those already invested in marijuana stocks (and those thinking about becoming invested in marijuana stocks) may want to approach it. What does the author identify as the real reason behind the run-up, what do money flows from the “smart money” indicate, and what might various types of pot stock investors – and prospective pot stock investors – want to do now? CLICK HERE.
What’s Better Than Buying The Dip? This Strategy, It Turns Out
If you were sent back in time 40 years and had the option of either investing $100 in the S&P 500 every month for the next 40 years (dollar cost averaging) or saving $100 each month and, having the ability to know when the market was at an absolute bottom between two all-time highs, only invested when the S&P 500 was in a dip (buying the dip), which approach would you be better off choosing? The prevailing wisdom is that buying the dip is superior – but, according to a recent study, that prevailing wisdom is wrong. For more, CLICK HERE.
5 Stocks With Small Price Tags And Big Upside Potential
Low-priced stocks offer investors – especially more aggressive traders – the opportunity to not only make a decent profit in the event of even relatively small price moves, but also to buy more shares than they would be able to of large-cap stocks. Today’s article highlights five stocks trading under $10 that the authors believe “While more suited for aggressive accounts… could prove exciting additions to portfolios looking for solid alpha potential.” For these five stocks – including a company that “could be poised for big gains as liquefied natural gas (LNG) exporting continues to ramp higher”, CLICK HERE.
Why The Latest Report Makes Starbucks Stock All The More Appetizing
“As always, the latest report can confirm or change opinions about a stock,” notes the author of today’s article. So what does the latest report from Starbucks indicate about the attractiveness of its stock for investors? The author takes a detailed look at the contents of the report and how analysts’ response to it could drive the next price move for Starbucks stock – a price move that investors may want to buy into. For more – including how investors may want to go about establishing a position – CLICK HERE.
After A Terrible December And A Terrific January, More Upside — Or Trouble — Ahead For Stocks?
After its worst December since 1931, the S&P just posted its best January performance since 1987. The question now is whether there is more upside ahead (and thus now is a time to buy) or whether there is trouble ahead. One technical analyst in the “trouble ahead” camp is pointing to two specific developments that may be warning signs for stocks – one development related to small-cap stocks and one related to gold which he states “could be an isolated event, [or] could mean something more.” For more, CLICK HERE.
The Many ETF Paths To Income
“Whether your focus is big companies or small, domestic corporations or international ones, there are ETFs where income-oriented investors can find investments that pay more than the average S&P 500 index component,” notes the author of today’s article – who proceeds to highlight nine income-focused ETFs which, while focusing on different categories of stocks (e.g. large-cap, preferred, low-volatility) and employing different strategies (e.g. current dividend yield vs. dividend growth) offer above-average dividends. For more, CLICK HERE.
Which Stock Wins Wall Street’s Battle Of The “Cannabis Contenders”?
Which of the top cannabis stocks listed in the U.S. is the consensus favorite of Wall Street? Today’s article ranks the top “cannabis contenders” (including Canopy Growth, Aurora Cannabis, Tilray and Zynerba Pharmaceuticals) based on analyst ratings and upside potential – and while it comes down to a close race between two cannabis stocks, one stock is ultimately singled out as Wall Street’s favorite to buy. For more, CLICK HERE.
Big-Name Money Managers Are Making Big Bets On These 2 “Best Idea” Stocks
“Very few people have gotten rich on their seventh best idea, but a lot of people have gotten rich with their best idea,” Warren Buffett is quoted as having said – and today’s article looks at what two big-name money managers appear to consider among their best investment ideas, based on the fact that they have substantial portions of their portfolios tied up in these single stocks. For these two potential “best idea” investments – a health care stock and a memory chip maker stock –
CLICK HERE.
Buy The Unloved 2.0: An Updated Take On A Successful Contrarian Strategy
The Buy the Unloved investment strategy has investors invest equal sums in the three equity categories of the previous year that had the largest outflows, then sell the stakes after three years and repeat the process. And this contrarian strategy has performed well. Today’s article looks at how to carry out the traditional version of this strategy for 2019 (including some specific investments for doing so), as well as an updated version of the strategy. For more, CLICK HERE.
Reaching The “Magical” Dividend Crossover Point
For dividend investors looking to achieve financial independence, the author of today’s article notes that the key is reaching the dividend crossover point – “The magic point…where the dividend income exceeds the expenses of the dividend investor”. Reaching the dividend crossover point isn’t easy, however, and the author identifies the key ingredients to doing so, as well as some rules to follow “in order to create s sustainable dividend producing machine, which would produce dependable income for decades.” For more,
CLICK HERE.